Dr Natalie Kathleen Rochester, PHD | |
7400 Merton Minter St, San Antonio, TX 78229-4404 | |
(210) 699-2100 | |
Not Available |
Full Name | Dr Natalie Kathleen Rochester |
---|---|
Gender | Female |
Speciality | Psychologist |
Location | 7400 Merton Minter St, San Antonio, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003259714 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YS0200X | Counselor - School | (* (Not Available)) | Secondary |
103T00000X | Psychologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Natalie Kathleen Rochester, PHD 7400 Merton Minter St, San Antonio, TX 78229-4404 Ph: (210) 699-2100 | Dr Natalie Kathleen Rochester, PHD 7400 Merton Minter St, San Antonio, TX 78229-4404 Ph: (210) 699-2100 |
News Archive
Mobile phone use "may increase the risk of certain types of brain cancer in humans," therefore "consumers should consider ways of reducing their exposure," a WHO/International Agency for Research on Cancer (IARC) working group concluded on Tuesday, Reuters reports.
RelayHealth, a leading provider of healthcare connectivity services, today announced that 50 health systems and hospitals are now contracted for its solutions to facilitate health information exchange (HIE) and care coordination.
COVID-19 Reflections: Severe lockdowns and Stay-at-Home orders have been hallmark of the national and global response to this Pandemic. They have been imposed with little precedent and scant evidence of their effectiveness as opposed to less restrictive social distancing measures.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
› Verified 5 days ago